Effect of Superoxide Dismutase on Bleomycin-Induced Dermal Sclerosis: Implications for the Treatment of Systemic Sclerosis
Toshiyuki Yamamoto(Fukushima Medical University), Yutaka Mizushima(St. Marianna University School of Medicine), Shinsuke Takagawa(Tokyo Medical and Dental University), Ichiro Katayama(The University of Osaka), Kiyoshi Nishioka(Tokyo Medical and Dental University)
Cited by 60
Related Papers
Animal Model of Sclerotic Skin. I: Local Injections of Bleomycin Induce Sclerotic Skin Mimicking Scleroderma
|Journal of Investigative Dermatology|1999|437
Towards global consensus on outcome measures for atopic eczema research: results of the <scp>HOME II</scp> meeting
|Allergy|2012|189
Sustained Activation of Fibroblast Transforming Growth Factor-β/Smad Signaling in a Murine Model of Scleroderma
|Journal of Investigative Dermatology|2003|122
Periostin Facilitates Skin Sclerosis via PI3K/Akt Dependent Mechanism in a Mouse Model of Scleroderma
|PLoS ONE|2012|105
6-Shogaol Protects Human Melanocytes against Oxidative Stress through Activation of the Nrf2-Antioxidant Response Element Signaling Pathway
|International Journal of Molecular Sciences|2020|61